A Genome-Wide Association Study Identifies Susceptibility Variants for Type 2 Diabetes in Han Chinese

To investigate the underlying mechanisms of T2D pathogenesis, we looked for diabetes susceptibility genes that increase the risk of type 2 diabetes (T2D) in a Han Chinese population. A two-stage genome-wide association (GWA) study was conducted, in which 995 patients and 894 controls were genotyped using the Illumina HumanHap550-Duo BeadChip for the first genome scan stage. This was further replicated in 1,803 patients and 1,473 controls in stage 2. We found two loci not previously associated with diabetes susceptibility in and around the genes protein tyrosine phosphatase receptor type D (PTPRD) (P = 8.54×10−10; odds ratio [OR] = 1.57; 95% confidence interval [CI] = 1.36–1.82), and serine racemase (SRR) (P = 3.06×10−9; OR = 1.28; 95% CI = 1.18–1.39). We also confirmed that variants in KCNQ1 were associated with T2D risk, with the strongest signal at rs2237895 (P = 9.65×10−10; OR = 1.29, 95% CI = 1.19–1.40). By identifying two novel genetic susceptibility loci in a Han Chinese population and confirming the involvement of KCNQ1, which was previously reported to be associated with T2D in Japanese and European descent populations, our results may lead to a better understanding of differences in the molecular pathogenesis of T2D among various populations.

[1]  Yun Liu,et al.  The E23K variation in the KCNJ11 gene is associated with type 2 diabetes in Chinese and East Asian population , 2009, Journal of Human Genetics.

[2]  E. Schleicher,et al.  Enhanced insulin sensitivity of gene-targeted mice lacking functional KCNQ1. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.

[3]  F. Takeuchi,et al.  Confirmation of Multiple Risk Loci and Genetic Impacts by a Genome-Wide Association Study of Type 2 Diabetes in the Japanese Population , 2009, Diabetes.

[4]  K. Xiang,et al.  Variations in KCNQ1 are associated with type 2 diabetes and beta cell function in a Chinese population , 2009, Diabetologia.

[5]  L. Groop,et al.  A common variant in MTNR1B, encoding melatonin receptor 1B, is associated with type 2 diabetes and fasting plasma glucose in Han Chinese individuals , 2009, Diabetologia.

[6]  Barbara Heude,et al.  Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations , 2009, Nature Genetics.

[7]  K. Xiang,et al.  Common Variants of Hepatocyte Nuclear Factor 1β Are Associated With Type 2 Diabetes in a Chinese Population , 2009, Diabetes.

[8]  P. Elliott,et al.  A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk , 2009, Nature Genetics.

[9]  D. Altshuler,et al.  Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion , 2009, Nature Genetics.

[10]  Inês Barroso,et al.  Variants in MTNR1B influence fasting glucose levels , 2009, Nature Genetics.

[11]  F. Hu,et al.  Common Variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE Genes Are Associated With Type 2 Diabetes and Impaired Fasting Glucose in a Chinese Han Population , 2008, Diabetes.

[12]  T. Hansen,et al.  SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations , 2008, Nature Genetics.

[13]  L. Groop,et al.  Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus , 2008, Nature Genetics.

[14]  Herman Wolosker,et al.  d‐Amino acids in the brain: d‐serine in neurotransmission and neurodegeneration , 2008, The FEBS journal.

[15]  M. McCarthy,et al.  Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes , 2008, Nature Genetics.

[16]  Yusuke Nakamura,et al.  Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 With Susceptibility to Type 2 Diabetes in a Japanese Population , 2008, Diabetes.

[17]  J. Florez,et al.  Genetic susceptibility to type 2 diabetes and implications for antidiabetic therapy. , 2008, Annual review of medicine.

[18]  J. Philippe,et al.  Pax-6 and c-Maf Functionally Interact with the α-Cell-specific DNA Element G1 in Vivo to Promote Glucagon Gene Expression* , 2007, Journal of Biological Chemistry.

[19]  L. Chuang,et al.  Association Study of the Genetic Polymorphisms of the Transcription Factor 7-Like 2 (TCF7L2) Gene and Type 2 Diabetes in the Chinese Population , 2007, Diabetes.

[20]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[21]  M. McCarthy,et al.  Common variants in WFS1 confer risk of type 2 diabetes , 2007, Nature Genetics.

[22]  D. Gudbjartsson,et al.  Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes , 2007, Nature Genetics.

[23]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[24]  M. McCarthy,et al.  Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes , 2007, Science.

[25]  Marcia M. Nizzari,et al.  Genome-Wide Association Analysis Identifies Loci for Type 2 Diabetes and Triglyceride Levels , 2007, Science.

[26]  J. Gulcher,et al.  A variant in CDKAL1 influences insulin response and risk of type 2 diabetes , 2007, Nature Genetics.

[27]  G. Abecasis,et al.  A Genome-Wide Association Study of Type 2 Diabetes in Finns Detects Multiple Susceptibility Variants , 2007, Science.

[28]  Kristin G Ardlie,et al.  Evaluation of Common Variants in the Six Known Maturity-Onset Diabetes of the Young (MODY) Genes for Association With Type 2 Diabetes , 2007, Diabetes.

[29]  T. Hudson,et al.  A genome-wide association study identifies novel risk loci for type 2 diabetes , 2007, Nature.

[30]  A. Marette,et al.  Altered glucose homeostasis in mice lacking the receptor protein tyrosine phosphatase sigma. , 2006, Canadian journal of physiology and pharmacology.

[31]  K. Tsuchiya,et al.  Potential Roles of Large Mafs in Cell Lineages and Developing Pancreas , 2006, Pancreas.

[32]  W. Pan,et al.  Han Chinese Cell and Genome Bank in Taiwan: Purpose, Design and Ethical Considerations , 2006, Human Heredity.

[33]  H. Stefánsson,et al.  Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes , 2006, Nature Genetics.

[34]  J. Minna,et al.  Identification of chromosome arm 9p as the most frequent target of homozygous deletions in lung cancer , 2005, Genes, chromosomes & cancer.

[35]  Michael Stumvoll,et al.  Type 2 diabetes: principles of pathogenesis and therapy , 2005, The Lancet.

[36]  Dimitrios Iliopoulos,et al.  Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer , 2005, Oncogene.

[37]  F. Ris,et al.  Effects of I(Ks) channel inhibitors in insulin-secreting INS-1 cells. , 2005, Pflugers Archiv : European journal of physiology.

[38]  H. Homma,et al.  Whole body autoradiographic study on the distribution of14C-d-serine administered intravenously to rats , 2005, Amino Acids.

[39]  M. Tremblay,et al.  Functional significance of the LAR receptor protein tyrosine phosphatase family in development and diseases. , 2004, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[40]  K. Tsuchiya,et al.  Developmental contribution of c-maf in the kidney: distribution and developmental study of c-maf mRNA in normal mice kidney and histological study of c-maf knockout mice kidney and liver. , 2004, Biochemical and biophysical research communications.

[41]  M. Daly,et al.  Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region. , 2004, Diabetes.

[42]  J. Hokanson,et al.  Linkage of the metabolic syndrome to 1q23-q31 in Hispanic families: the Insulin Resistance Atherosclerosis Study Family Study. , 2004, Diabetes.

[43]  C. Croce,et al.  The Tumor Suppressor Gene WWOX at FRA16D Is Involved in Pancreatic Carcinogenesis , 2004, Clinical Cancer Research.

[44]  K. Yasuda,et al.  Differentially expressed Maf family transcription factors, c-Maf and MafA, activate glucagon and insulin gene expression in pancreatic islet alpha- and beta-cells. , 2004, Journal of molecular endocrinology.

[45]  G. Nijpels,et al.  Mitochondrial diabetes: molecular mechanisms and clinical presentation. , 2004, Diabetes.

[46]  Massimo Gadina,et al.  Cytokines and Transcription Factors That Regulate T Helper Cell Differentiation: New Players and New Insights , 2003, Journal of Clinical Immunology.

[47]  H. Ledermann,et al.  Maturity-onset diabetes of the young (MODY) at least ten times more common in Europe than previously assumed? , 1995, Diabetologia.

[48]  G. Nijpels,et al.  Molecular mechanisms and clinical presentation , 2004 .

[49]  K. Xiang,et al.  Genome-wide search for type 2 diabetes/impaired glucose homeostasis susceptibility genes in the Chinese: significant linkage to chromosome 6q21-q23 and chromosome 1q21-q24. , 2004, Diabetes.

[50]  K. Omoteyama,et al.  Regulation and differential expression of the c-maf gene in differentiating cultured cells. , 2003, Biochemical and biophysical research communications.

[51]  Ying Wang,et al.  KCNQ1 gain-of-function mutation in familial atrial fibrillation. , 2003, Science.

[52]  C. Croce,et al.  WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer. , 2003, Cancer research.

[53]  T. Hansen,et al.  The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes. , 2003, Diabetes.

[54]  C. Bouchard,et al.  Genomic scan of glucose and insulin metabolism phenotypes: the HERITAGE Family Study. , 2003, Metabolism: clinical and experimental.

[55]  M. Wagner,et al.  Genome-wide and fine-mapping linkage studies of type 2 diabetes and glucose traits in the Old Order Amish: evidence for a new diabetes locus on chromosome 14q11 and confirmation of a locus on chromosome 1q21-q24. , 2003, Diabetes.

[56]  M. McCarthy,et al.  Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. , 2003, Diabetes.

[57]  Wei Huang,et al.  KCNQ1 Gain-of-Function Mutation in Familial Atrial Fibrillation , 2003, Science.

[58]  K. Xiang,et al.  Genome-Wide Search for Type 2 Diabetes / Impaired Glucose Homeostasis Susceptibility Genes in the Chinese Significant Linkage to Chromosome 6 q 21-q 23 and Chromosome 1 q 21-q 24 , 2003 .

[59]  T. Hansen,et al.  The E 23 K Variant of Kir 6 . 2 Associates With Impaired Post – OGTT Serum Insulin Response and Increased Risk of Type 2 Diabetes , 2003 .

[60]  R. Panizzutti,et al.  Cofactors of serine racemase that physiologically stimulate the synthesis of the N-methyl-d-aspartate (NMDA) receptor coagonist d-serine , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[61]  C. Croce,et al.  Genetic alterations of the tumor suppressor gene WWOX in esophageal squamous cell carcinoma. , 2002, Cancer research.

[62]  S. Asa,et al.  Pituitary, pancreatic and gut neuroendocrine defects in protein tyrosine phosphatase-sigma-deficient mice. , 2002, Molecular endocrinology.

[63]  J. Shaw,et al.  Global and societal implications of the diabetes epidemic , 2001, Nature.

[64]  G I Bell,et al.  Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. , 2001, The New England journal of medicine.

[65]  D J Porteous,et al.  WWOX: A candidate tumor suppressor gene involved in multiple tumor types , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[66]  R Foxon,et al.  A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. , 2001, American journal of human genetics.

[67]  M. Pani,et al.  Overexpression of the LAR (leukocyte antigen-related) protein-tyrosine phosphatase in muscle causes insulin resistance , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[68]  M. Franz,et al.  Targeted disruption of the Kcnq1 gene produces a mouse model of Jervell and Lange– Nielsen Syndrome , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[69]  A. Moorman,et al.  Differential expression of KvLQT1 and its regulator IsK in mouse epithelia. , 2001, American journal of physiology. Cell physiology.

[70]  A. Feinberg,et al.  Targeted disruption of the Kvlqt1 gene causes deafness and gastric hyperplasia in mice. , 2000, The Journal of clinical investigation.

[71]  C. Dina,et al.  Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. , 2000, American journal of human genetics.

[72]  C. Langefeld,et al.  Further evidence for a susceptibility locus for type 2 diabetes on chromosome 20q13.1-q13.2. , 2000, Diabetes.

[73]  R. Richards,et al.  Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells. , 2000, Human molecular genetics.

[74]  K. Mikoshiba,et al.  Impaired learning with enhanced hippocampal long‐term potentiation in PTPδ‐deficient mice , 2000 .

[75]  D. Linden,et al.  D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[76]  A. Bednarek,et al.  WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. , 2000, Cancer research.

[77]  E S Lander,et al.  The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. , 2000, Nature genetics.

[78]  S H Snyder,et al.  Serine racemase: a glial enzyme synthesizing D-serine to regulate glutamate-N-methyl-D-aspartate neurotransmission. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[79]  M. Leppert,et al.  A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians. , 1999, Diabetes.

[80]  Tiansen Li,et al.  Requirement for the c-Maf transcription factor in crystallin gene regulation and lens development. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[81]  F. Collins,et al.  Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[82]  K N Sheth,et al.  Purification of serine racemase: biosynthesis of the neuromodulator D-serine. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[83]  M. Ehm,et al.  An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. , 1998, American journal of human genetics.

[84]  G. Shulman,et al.  Transgenic mice deficient in the LAR protein-tyrosine phosphatase exhibit profound defects in glucose homeostasis. , 1998, Diabetes.

[85]  M. Lazdunski,et al.  Properties of KvLQT1 K+ channel mutations in Romano–Ward and Jervell and Lange‐Nielsen inherited cardiac arrhythmias , 1997, The EMBO journal.

[86]  J. Beckmann,et al.  A susceptibility locus for early-onset non-insulin dependent (type 2) diabetes mellitus maps to chromosome 20q, proximal to the phosphoenolpyruvate carboxykinase gene. , 1997, Human molecular genetics.

[87]  S. Rich,et al.  Linkage of Genetic Markers on Human Chromosomes 20 and 12 to NIDDM in Caucasian Sib Pairs With a History of Diabetic Nephropathy , 1997, Diabetes.

[88]  S. Rich,et al.  New Susceptibility Locus for NIDDM Is Localized to Human Chromosome 20q , 1997, Diabetes.

[89]  Kazuhiko Yoshida,et al.  Rat maf related genes: specific expression in chondrocytes, lens and spinal cord , 1997, Oncogene.

[90]  P. Coumel,et al.  A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome , 1997, Nature Genetics.

[91]  M. Sanguinetti,et al.  Coassembly of KVLQT1 and minK (IsK) proteins to form cardiac IKS potassium channel , 1996, Nature.

[92]  Jacques Barhanin,et al.  KvLQT1 and IsK (minK) proteins associate to form the IKS cardiac potassium current , 1996, Nature.

[93]  M. Sanguinetti,et al.  Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. , 1996, Nature.

[94]  G. Landes,et al.  Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias , 1996, Nature Genetics.

[95]  R. Pulido,et al.  The LAR/PTP delta/PTP sigma subfamily of transmembrane protein-tyrosine-phosphatases: multiple human LAR, PTP delta, and PTP sigma isoforms are expressed in a tissue-specific manner and associate with the LAR-interacting protein LIP.1. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[96]  T. Iwanaga,et al.  Expression and role of ionotropic glutamate receptors in pancreatic islet cells , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[97]  J. Miyazaki,et al.  Functional neuronal ionotropic glutamate receptors are expressed in the non-neuronal cell line MIN6. , 1994, The Journal of biological chemistry.

[98]  J. Bockaert,et al.  Glutamate stimulates glucagon secretion via an excitatory amino acid receptor of the AMPA subtype in rat pancreas. , 1993, European journal of pharmacology.

[99]  S WRIGHT,et al.  Genetical Structure of Populations , 1950, British medical journal.